⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress
globenewswire.com
LLY
Direct Relief Medical Aid to U.S. Safety Net Tops $3 Billion
accessnewswire.com
TEVA
LLY
ABBV
ALC
JNJ
SNY
PFE
FDX
ABT
Sitryx to Participate in Upcoming Investor Conferences
globenewswire.com
LLY
GSK
Chondrosarcoma Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight
globenewswire.com
INBX
LLY
PFE
NVS
BMY
EXEL
JNJ
AZN
JAZZ
TLRY
Lilly to participate in Morgan Stanley 24th Annual Global Healthcare Conference
prnewswire.com
LLY
Global Anti-Obesity Drugs Market Report 2026: Set to Reach $106.5 Billion by 2035 as GLP-1 Therapies Transform Obesity Care
globenewswire.com
OPK
NVO
LLY
TEVA
New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity
prnewswire.com
LLY
Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases
prnewswire.com
LLY
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI
prnewswire.com
ATAI
LLY
Breast Cancer Therapeutics Market Size to Reach USD 95.14 Billion at a CAGR of 9.20% from 2035 – SNS Insider
globenewswire.com
PFE
LLY
MRK
GILD
ABBV
BMY
AMGN
PBYI
GSK
TEVA
EXEL